A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2004
10/20/2004	EP1468686A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
10/20/2004	EP1468684A1 Sigma receptor binder containing indanone derivative
10/20/2004	EP1468679A2 Controlled release formulation containing tramadol
10/20/2004	EP1468293A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases
10/20/2004	EP1468091A2 Transmembrane protein
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators
10/20/2004	EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
10/20/2004	EP1467994A1 Pteridine derivatives, method for the production thereof, and use thereof
10/20/2004	EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
10/20/2004	EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF&colon; MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION
10/20/2004	EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
10/20/2004	EP1467972A1 Indazole compounds useful as protein kinase inhibitors
10/20/2004	EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004	EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004	EP1467769A1 A method for preparing resinates
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
10/20/2004	EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
10/20/2004	EP1467737A1 Orally dispersible pharmaceutical piribedil composition
10/20/2004	EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b
10/20/2004	EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
10/20/2004	EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
10/20/2004	EP1467728A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
10/20/2004	EP1467727A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
10/20/2004	EP1467726A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
10/20/2004	EP1467724A1 Orodispersible pharmaceutical composition comprising agomelatine
10/20/2004	EP1467723A1 Phenyl sulfoxides and phenyl sulfones
10/20/2004	EP1467718A1 Method of treatment of a patient requiring analgesia
10/20/2004	EP1467714A1 Drug mixture with enhanced dissolution rate
10/20/2004	EP1368327B1 Benzo thiadiazine matrix metalloproteinase inhibitors
10/20/2004	EP1263725B1 Novel compounds
10/20/2004	EP1261588B1 IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS
10/20/2004	EP1246619B1 Urotensin-ii receptor antagonists
10/20/2004	EP1230236B1 Compound with growth hormone releasing properties
10/20/2004	EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004	EP1204660B1 Serotonergic benzothiophenes
10/20/2004	EP1198477B1 Prolactin-releasing peptide and use in treating pain
10/20/2004	EP1183015B1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
10/20/2004	EP1171141B1 MEDICAMENT FOR INHIBITING THE NF-kB TRANSCRIPTION FACTOR
10/20/2004	EP1161239B1 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis
10/20/2004	EP1157005B1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
10/20/2004	EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004	EP1143967B1 Use of anticonvulsant derivatives for treating cluster headaches
10/20/2004	EP1112253B1 Branched alkyl pyrrolidine-3-carboxylic acids
10/20/2004	EP0866696B1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc
10/20/2004	EP0830136B1 New cryptophycins from synthesis
10/20/2004	CN2648834Y Smoking-stopping holder
10/20/2004	CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists
10/20/2004	CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease
10/20/2004	CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them
10/20/2004	CN1538956A Spiro compounds
10/20/2004	CN1538955A Pyrrolidine derivatives as factor Xa inhibitors
10/20/2004	CN1538848A Novel Benzo-fused heterocycles
10/20/2004	CN1538846A Oral administration of 6-hydroxy-oxymorphone for use as antalgesic
10/20/2004	CN1538845A Phenyl derivatives as factor Xa inhibitors
10/20/2004	CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use
10/20/2004	CN1538843A Neurotrophic tacrolimus analogs
10/20/2004	CN1538840A Perfume compositions
10/20/2004	CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
10/20/2004	CN1537625A Traditional Chinese medicine tablet prepn. method
10/20/2004	CN1537624A Soft capsule, and its prepn. method
10/20/2004	CN1537602A Traditional Chinese medicine pill for taking care of heart, brain and kidney
10/20/2004	CN1537595A Zuanshanfeng granule and its prepn. method
10/20/2004	CN1537573A Extraction of active ingredient of Zuanshanfeng, and method for preparing its prepn.
10/20/2004	CN1537571A Strong Rhizoma Gastrodiae and eucommia bark granule, and its prepn. method
10/20/2004	CN1537550A Compound traditional Chinese medicine prepn. for treating symptom of delayed giving-up of opium, and its application
10/20/2004	CN1537549A Compound traditional Chinese medicine prepn. for treating symptom after giving up analeptic, and its application
10/20/2004	CN1537533A Method for preparing medicine of levo-stephandinine
10/20/2004	CN1537531A Celecoxib compositions
10/20/2004	CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
10/20/2004	CN1171883C Nonsteroidal antiinflammatories
10/20/2004	CN1171868C Novel carbamic acid ester compound containing amino thionic group and producing process
10/20/2004	CN1171620C Health-care food for improving sleep
10/20/2004	CN1171595C Production process of obtaining non-toxic effective buthotoxin and medicine prepared by the process for treating apilepsy
10/20/2004	CN1171586C Pharmaceutical compositions comprising monoamine oxidase B inhibitors
10/20/2004	CN1171585C Pharmaceutical preparations containing dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease
10/20/2004	CN1171583C Medical percutaneous preparation containing hydrophilic or salt form
10/19/2004	US6806376 Method for the preparation of citalopram
10/19/2004	US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004	US6806312 Thermoplastic resin composition
10/19/2004	US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/19/2004	US6806282 Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
10/19/2004	US6806281 Treatment of cocaine abuse, parkinson's disease
10/19/2004	US6806270 Selective antagonists of A2B adenosine receptors
10/19/2004	US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
10/19/2004	US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent
10/19/2004	US6806255 Compounds and methods for modulating adhesion molecule function
10/19/2004	US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
10/19/2004	CA2308783C Novel derivatives of 1-aza-2-alkyl-6-aryl-cycloalkanes, process for their preparation and pharmaceutical compositions containing them
10/19/2004	CA2296901C Piperidine derivates having anxiolytic effect
10/19/2004	CA2155796C 2,3-dihydro-1h-isoindole derivatives, a process for their preparation and their use as serotonin reuptake inhibitors
10/14/2004	WO2004087948A1 Single nucleotide polymorphisms for the diagnosis and treatment of schizophrenia spectrum disorders
10/14/2004	WO2004087938A1 Novel physiologically active substances pf1270a, b and c
10/14/2004	WO2004087763A1 Modified antibody against cd22 and utilization thereof
10/14/2004	WO2004087744A2 Composition and method for nerve regeneration
10/14/2004	WO2004087710A1 Pyrrolo`1,2-b!pyridazine compounds and their use as crf1 receptor antagonists
10/14/2004	WO2004087709A1 Pyrrolo[1,2-b]pyridazine compounds and their uses
10/14/2004	WO2004087708A1 Pyrrolo (1,2-b) pyridazine compounds and their use as cfr-1 receptor antagonists

1 ... 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 ... 1833